Search

Author/Creator Ozaki, Kai

1. Association of oncological response between the first‐line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma. (29th December 2021)

Authors:
Ozaki, Kai; Hatakeyama, Shingo; Hamaya, Tomoko; Okita, Kazutaka; Hashimoto, Yasuhiro; Ohyama, Chikara
Journal:
International journal of urology
Issue:
Volume 29:Number 4(2022)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. MP30-09 DEVELOPMENT OF A NOVEL DIAGNOSTIC MODEL FOR UROLOGICAL CANCERS USING COMPREHENSIVE N-GLYCAN SIGNATURES OF SERUM IMMUNOGLOBULINS WITH A MACHINE LEARNING APPROACH. (May 2022)

Authors:
Iwamura, Hiromichi; Yoneyama, Tohru; Kodama, Hirotake; Ozaki, Kai; Ozaki, Yusuke; Okita, Kazutaka; Konishi, Sakae; Narita, Takuma; Fujita, Naoki; Kojima, Yuta; Okamoto, Teppei; Tobisawa, Yuki; Yamamoto, Hayato; Hatakeyama, Shingo; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Ohyama, Chikara
Journal:
Journal of urology
Issue:
Volume 207(2022)Supplement 5
Page Start:
e481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma. Issue 2 (8th October 2021)

Authors:
Ozaki, Kai; Hatakeyama, Shingo; Tanaka, Toshikazu; Noro, Daisuke; Tokui, Noriko; Horiguchi, Hirotaka; Okuyama, Yoshiharu; Fujita, Naoki; Okamoto, Teppei; Okamoto, Akiko; Suzuki, Yuichiro; Yamamoto, Hayato; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Ohyama, Chikara
Journal:
BJUI Compass
Issue:
Volume 3:Issue 2(2022)
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗